1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Intradermal Injections Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Intradermal Injections Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Intradermal Injections Market Regional Analysis
6.2 North America Intradermal Injections Market Revenue 2019-2028 (US$ Million)
6.3 North America Intradermal Injections Market Forecast Analysis
7. North America Intradermal Injections Market Analysis – by Method
7.1 Normal Sized Needle
- 7.1.1 Overview
- 7.1.2 Normal Sized Needle: North America Intradermal Injections Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Short Needle
- 7.2.1 Overview
- 7.2.2 Short Needle: North America Intradermal Injections Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Without Needle
- 7.3.1 Overview
- 7.3.2 Without Needle: North America Intradermal Injections Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Intradermal Injections Market Analysis – by Application
8.1 Tuberculin Skin Test
- 8.1.1 Overview
- 8.1.2 Tuberculin Skin Test: North America Intradermal Injections Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Allergy Test
- 8.2.1 Overview
- 8.2.2 Allergy Test: North America Intradermal Injections Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Local Aesthetics
- 8.3.1 Overview
- 8.3.2 Local Aesthetics: North America Intradermal Injections Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Intradermal Injections Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Intradermal Injections Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: North America Intradermal Injections Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Academics and Research Institutes
- 9.3.1 Overview
- 9.3.2 Academics and Research Institutes: North America Intradermal Injections Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Intradermal Injections Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Intradermal Injections Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 North America Intradermal Injections Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Intradermal Injections Market Breakdown, by Method
- 10.2.1.1.2 US: North America Intradermal Injections Market Breakdown, by Application
- 10.2.1.1.3 US: North America Intradermal Injections Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Intradermal Injections Market Breakdown, by Method
- 10.2.1.2.2 Canada: North America Intradermal Injections Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Intradermal Injections Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Intradermal Injections Market Breakdown, by Method
- 10.2.1.3.2 Mexico : North America Intradermal Injections Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Intradermal Injections Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 BD.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 West Pharmaceutical Services, Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Terumo Corporation.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Nanopass.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 PharmaJet.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Idevax.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Eunsung Global.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Crossject.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Cardinal Health Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Hindustan Syringes and Medical Devices Ltd.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations